FSIP2 and breast cancer: In addition, ESR1, PALB2, FSIP2, AGRN, FRAS1, IGFN1, EDC4, OSBPL3 were found to be significantly more frequent in prospectively accrued metastatic breast cancers than in primary breast cancers from The Cancer Genome Atlas (TCGA) [32].